Effective enzyme thrombolytic composition on the basis of wild-type and chemically modified plasminogen activators.
Maksimenko
A V
AV
Institute of Experimental Cardiology, Russian Academy of Medical Sciences, Moscow, Russia.
Tischenko
E G
EG
Petrov
A D
AD
Petrova
M L
ML
D000818:Animals; D004285:Dogs; D007262:Infusions, Intravenous; D008657:Metabolic Clearance Rate; D011994:Recombinant Proteins; D013329:Structure-Activity Relationship; D013924:Thrombophlebitis / Q000188:drug therapy; D010959:Tissue Plasminogen Activator / Q000737:chemistry* / Q000493:pharmacokinetics; D014568:Urokinase-Type Plasminogen Activator / Q000737:chemistry* / Q000493:pharmacokinetics
D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator